CPHI

China Pharma Holdings, Inc.

NYSE AmericanUSDEQUITY DELAYED

0.98

▼ 0.08 (7.78%)

MARKET · —

Price

Open

1.04

Prev close

1.06

Day high

1.05

Day low

0.97

Volume

275.43K

Market cap

—

P/E (TTM)

—

52W range

0.38 – 19.19

Trailing performance

Price return · vs SPY

Returnvs SPY

-13.27% -11.9%

-47.03% -50.8%

+28.95% +25.9%

+60.66% +49.6%

YTD

-19.01% -31.3%

-31.47% -51.5%

-91.48% -165.6%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

1.09

-10.32% from price

SMA 20

1.15

-14.63% from price

SMA 50

1.11

-11.82% from price

SMA 100

0.90

+8.36% from price

SMA 200

1.01

-2.93% from price

EMA 12

1.12

-12.53% from price

EMA 26

1.18

-17.14% from price

EMA 50

1.13

-13.16% from price

RSI (14)

46.9

Neutral

MACD (12,26,9)

-0.06

Hist -0.04

ATR (14)

0.10

9.77% of price

Realised vol 30D

807.6%

Annualised

Bollinger upper

1.31

20, 2σ

Bollinger lower

0.99

20, 2σ

50 / 200 cross

Golden

1.11 vs 1.01

Trend bias

Below 200

-2.93%

Risk profile

Daily returns · 1Y window

Beta vs SPY

5.02

More volatile than market

Correlation to SPY

0.08

Largely independent

Realised vol 30D

807.6%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-87.9%

Peak to trough

Max drawdown 5Y

-99.9%

Peak to trough

ATR 14

0.10

9.77% of price

Beta (reported)

—

5Y monthly, from filing

Options chain

Account required

ExpirySpot 0.98

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Headlines

CPHI · links out to the publisher

China Pharma Holdings, Inc. Announces Closing of $5.0 Million Registered Direct Offering PR Newswire · 30d ago Top Midday Decliners MT Newswires · 31d ago China Pharma Announces Pricing of $5 Million Registered Direct Offering PR Newswire · 31d ago China Pharma Holdings, Inc. Comments on Unusual Market Activity PR Newswire · 32d ago China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity PR Newswire · 38d ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.